Surgical neurology international · 2026
Mortality rates in patients with Parkinson's disease: An analysis of the Global Burden of Disease database.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gould Jacob, Patel Saarang, Chaurasia Bipin
Аннотация
BACKGROUND: Parkinson's disease (PD) prevalence is rising globally; however, the implications for mortality remain underexplored. This study evaluates regional PD mortality trends over the past decade.
METHODS: Age-standardized PD mortality rates from 2011 to 2021 were extracted from the Global Burden of Disease 2021 database for all six World Health Organization regions. Relative changes over time were calculated to assess trends.
RESULTS: Mortality trends varied across regions. The Eastern Mediterranean region had the highest mortality in both 2011 (5.48/100,000) and 2021 (5.38/100,000). The Western Pacific Region saw the greatest decline (-5.67%), while the African Region showed minimal improvement (-0.82%). Two regions, the Americas and South-East Asia, experienced net increases.
CONCLUSION: PD mortality improvements are heterogeneous globally, which may reflect differences in access to diagnosis and treatment of PD and comorbidities. Targeted, region-specific strategies should be considered to reduce mortality disparities.
METHODS: Age-standardized PD mortality rates from 2011 to 2021 were extracted from the Global Burden of Disease 2021 database for all six World Health Organization regions. Relative changes over time were calculated to assess trends.
RESULTS: Mortality trends varied across regions. The Eastern Mediterranean region had the highest mortality in both 2011 (5.48/100,000) and 2021 (5.38/100,000). The Western Pacific Region saw the greatest decline (-5.67%), while the African Region showed minimal improvement (-0.82%). Two regions, the Americas and South-East Asia, experienced net increases.
CONCLUSION: PD mortality improvements are heterogeneous globally, which may reflect differences in access to diagnosis and treatment of PD and comorbidities. Targeted, region-specific strategies should be considered to reduce mortality disparities.